chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had little fever; Had hard time breathing; Heart was racing; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had little fever), DYSPNOEA (Had hard time breathing) and PALPITATIONS (Heart was racing) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Had little fever), DYSPNOEA (Had hard time breathing) and PALPITATIONS (Heart was racing). At the time of the report, PYREXIA (Had little fever), DYSPNOEA (Had hard time breathing) and PALPITATIONS (Heart was racing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
diarrhea 1 week, recommended fiber or 1/2 of prn norco at bedtime for a few nights,  has lost 14lbs
momentary sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (momentary sore throat) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (momentary sore throat). At the time of the report, OROPHARYNGEAL PAIN (momentary sore throat) outcome was unknown.            No concomitant medication were reported
Dizziness that intensifies when he lies down; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 2nd dose of Shingrix. In October 2020, 3 days after receiving Shingrix, the patient experienced dizziness. On an unknown date, the outcome of the dizziness was recovered/resolved.   It was unknown if the reporter considered the dizziness to be related to Shingrix.  Additional details were received as follows: The patient reported, four weeks ago of reporting date, the patient received Shingrix. He experienced dizziness that intensifies when he lies down, three days after receiving Shingrix. He stated that he recovered. The patient did not consent to follow-up.
Severe burning up the left side of my neck, head, and face. This lasted a few days...now just intermittent swelling and achiness.
7/14/22 1:22PM Pt mother called is stating pt recently got vaccines on L arm on 7/11/22 the next morning her arm looked like a bug bite and today this morning pt was itchy on her arm and now has red spots were injection was placed , mom tried putting bendayrl cream and zytrec med but is not helping and is getting worse  7/14/22 2:43PM mom - she states child got vaccines on 7/11- area of concern is L arm - Confirmed that she was given the DTAP on the L arm.   Mom states on 12th are was red and a bit swollen- looked like a bee sting- she applied benadryl cream and gave her zyrtec.   Today she woke up and the area looks like a large square (red) and is swollen are warm to touch. It is also really itchy.   Scheduled at 5pm - also asked mom to email me a photo pre appt. Mom agrees.   Patient missed appointment on 7/14/22 at 5PM. 7/18/22 9:04AM : Spoke with Mother, and pt was seen at an urgent care 7/14/22 for her concerns, per mother she was advised to continue the use of Benadryl for 24 hours. Mother reports today that patients arm is clearing up and mother had no further concerns at this time. Mother declined offer to schedule a f/u appt with out office. Mother advised that a VAERS report would be filed, due to the adverse reaction patient had. Mother had no further questions at this time.
Sudden severe painful gout in my left knee.  I went on an errand and when I was getting out of my vehicle in my garage I almost could not walk from pain.  Before that I only had untreated gout in my left foot.   I still have gout pain in my left knee while walking as of today.
Patient fainted in lobby. initial BP 74/40 HR 45, patient pale, placed cool wash cloth on patient and offered snacks and water. Vitals retaken at 943 BP 95/61 HR 58, after some minutes patient's color returned to face and patient was transferred to seated position. Vitals 104/67 HR 68. Assisted patient to standing position 108/73 HR 71. PCP aware and patient stated he was feeling back to normal. PCP released patient to leave with parent and educated patient to move slowly and eat/stay hydrated.
1030PM began having emesis & 3 additional times during noc;20NOV96 emesis 102hr w/o formula, diluted;exp chills, legs & arms shakey;12noon 20NOV96 t101.6;inc sleep;localized rx @ inj site;
Information has been received from an office manager concerning a 73 year old female patient with hypertension and hypercholesterolaemia and a history of thyroid nodule and lung nodule who in 19-NOV-2008 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX (LOT# 661577/1161X). First dose was given on 2003. Concomitant therapy included alendronate sodium, ZOLOFT, ALTACE, amlodipine, aspirin and influenza virus vaccine (unspecified). The reporter stated that in the evening of 19-NOV-2008 the patient experienced an injection site reaction on her left deltoid, a redness and cellulitis-like reaction of half of her upper arm. An unspecified antibiotic was prescribed. Her outcome was unknown. Follow-up information has been received from a health professional concerning a 73 year old female retired patient with no known drug allergies who on 19-NOV-2008 was vaccinated intramuscularly in her left deltoid with a 0.5 ml dose of PNEUMOVAX (LOT# 661577/1161X). First dose was given on 7-NOV-2003. It was reported that the patient developed a lump "the size of a quarter" the day of the vaccination. The next day "3/4 of the upper arm" was red and warm. At the time of reporting it is unknown if the patient recovered. No further information is available.
Half hour after injection, pt c/o burning in throat and tightness in chest. Given BENADRYL. Pt has asthma, used PROAIR Inhaler x 3. Coughing. After 45 minutes pt felt better and requested to leave. One and a half hours later, pt c/o flushing, burning in throat and heart racing. 911 called and pt transported.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: Rash: red, "looked like measules" whole chest was "peppered with red dots', localized on chest and some near injection site. Lasted about 24 hours. Did not use anything to releave it, did not contact any provider.
This spontaneous report was received from a physician assistant and refers to a 66 year old female patient. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. In 2007(reported as about "11 years ago"), the patient was vaccinated with first dose of PNEUMOVAX 23 injection for "Prevention for pneumococcal disease" (route of administration, lot #, expiration date were not reported). In 2011 (reported as "about 7 years ago"), the patient experienced a rash that looked like a mosquito bite at the injection site. The physician assistant reported that, the patient was getting the rash once a year for about 7 years. No treatment was given for the adverse event. The patient did not seek medical attention. The outcome of the event was unknown. Casual relatedness between the event and the PNEUMOVAX 23 was not reported.
I contracted COVID-19, along with pneumonia and UTI infection. I had to seek care from the hospital. I had to stay in the hospital for 5 days for monitoring and I was released after 5 days.
Pt was given Anthrax, Typhoid & Hep B and about 30-45 mins later began to experience numbness & tingling in (R) side of her face & (R) arm. Pt was given BENADRYL w/some relief and monitored/observed in clinic.
Nerve damage, muscle weakness, loss of appetite, bone weakness, neuropathy, drop foot, vision loss (vision came back) hospital for months, out of work, can?t drive,
Moderna COVID?19 Vaccine EUA; immediate nausea, dizziness, headache; a few hours later, pain at shot location, body aches, strong thirst, moderate fatigue. Following day, nausea and dizziness went away; headache, body aches, thirst, and fatigue continued, pain at shot location stronger. Two days later, headache eased; body aches, thirst, and fatigue continued, pain at shot location lessened. Three days later, headache and fatigue; pain at shot location minimal.
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Headache-Medium, Error: Wrong Dose of Vaccine - Too High-, Additional Details: parent gave ibuprofen evening of vaccination
On or about the fourth day after the vaccine, I experienced what I would describe as "cranial" pain. It occurred only in two particular areas of my cranium. The pain was severe, but localized. It lasted for about 48 hrs. on and off. I was very tired and sleepy for most of the week following the injection. Sleeping seemed to help my cranial pain, somewhat. Then, on or about the 10th day after the vaccine, I developed congestion in my right Eustachian tube, causing my hearing to be compromised in the right ear. On about the 12th day, I developed a mechanical-type hissing noise that is bothersome, particularly at night; I believe it to be tinnitus.  As of today, 18 days post 1st. vacc, cranial pain has disappeared, but I'm still experiencing pain in and around the inner ear/eustachian tube of my right ear. Plus, I continue to have persistent, low-level tinnitus most of the day. The hearing on the right ear is not what it was before the Pfizer vaccine. I certainly hope  neither the tinnitus, nor the hearing loss is permanent.  I'm really wondering if it's contra indicated for me to get the second vaccination.
After 5-8 minutes I suddenly became hot/sweaty, pale, dizzy, nauseous, sudden drop in blood pressure, syncope. I was given epinephrine and a rapid response team was called and I was taken to the ED
My son started showing signs of fever, was sweating and irritable. I gave a dose of infants Tylenol at 6:30. He began having diarrhea around 7:00 PM and was screaming in pain for 3 hours after. From 2/26 until 3/1, he refused to eat solids and continued having acidic diarrhea every few hours each day. The fever continued and was recorded at 100.3 around noon Saturday 2/27, and recorder again at 101.7 at 6:00 PM the same day. Tylenol did bring the fever down but has been a continuous dosage every 6-8 hours for his symptoms. I brought him back to the doctors office where he received the vaccines on 3/1 to report the he reaction and was told he had rotavirus, but he was not tested and has been vaccinated for rotavirus.
Severe neck pain on the left side (opposite side than shot).  Took Advil but no help.
booster injection her arm itched for a week; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (booster injection her arm itched for a week) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. D11F21A, 031LZOA and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (booster injection her arm itched for a week). On 12-Nov-2021, VACCINATION SITE PRURITUS (booster injection her arm itched for a week) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Nov-2021, Blood test: high (High) liver enzymes were out of whack..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications Flu shot were reported. No treatment information was provided.
Chills, body aches, took ibuprofen to manage. Almost fainted. Nausea.
Four-degree (F) temperature spike (I can provide a plot: 96.0F to 100.0F) starting second day, ending 3rd day.  Involuntary, and melatonin-resistant insomnia (1am onward) starting night after 2nd Moderna shot. Resting heart-rate went from 58 to 65.
temperature excursion; This case was reported by a pharmacist via sales rep and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number LZ4N2, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Fluarix Quadrivalent 2021-2022 season .5 ml and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported. On 27th September 2021, the retail pharmacy called GSK medical information to obtain temperature excursion data because their wholesaler had contacted them to inform them that there had been a temperature excursion. Wholesaler asked pharmacy to quarantine the product. The product had already been administered to the patient. On 27th September 2021 the pharmacy did not yet have the specifics of the temperature excursion. They did not yet know whether the product had been stored above or below refrigerated temperatures nor did they know for how long. On 04th October 2021 GSK employee (Director for GSK, retail) learned the specific details of the temperature excursion. The product was shipped from GSK to the wholesaler via, but the shipment was lost and was sitting on a loading dock unrefrigerated for 2 weeks. The wholesaler then put the Fluarix product back in the refrigerator and subsequently shipped it to the pharmacy. Fluarix Quadrivalent (Influenza Vaccine) injectable suspension was available in 0.5 mL single-dose, disposable, prefilled Tip-Lok syringes (packaged without needles). GlaxoSmithKline (GSK) employee (Director for GSK, retail) called GSK response center on 6th October 2021 to report that the patient was vaccinated with Fluarix (FLU.QIV PRTC X10 CT FS US NH21, NDC: 59160-0887-52) which had been stored outside of the refrigerator for 2 weeks, which led to incorrect storage of drug. The pharmacy correctly stored the product in the refrigerator and unknowingly administered 1 dose to the patient. The GSK employee (Director for GSK, retail) did not have any specific patient information (example: gender). This is 1 of the 3 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021208229:same reporter US-GLAXOSMITHKLINE-US2021AMR208519:same reporter
Patient did not have any side effects and back at school the next day. Nursing staff misinterpreted written order. MD ordered FLULAVAL, 2nd MENACTRA and BEXSERO. Nursing staff thought the blank behind 2nd meant for the child to receive a 2nd GARDASIL-9 eventhough the word "GARDASIL" was not on the written order. Nursing staff should have come to me to clarify the order before administration if misunderstood.
Have lot of pain in body; whenever breathing in, it is like have pain in chest; pain in fingers everywhere; pain in feet/ sole; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 2021 (Lot number: FF2588) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Have lot of pain in body"; CHEST PAIN (non-serious) with onset 2021, outcome "not recovered", described as "whenever breathing in, it is like have pain in chest"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "not recovered", described as "pain in fingers everywhere"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "not recovered", described as "pain in feet/ sole". Therapeutic measures were not taken as a result of pain, chest pain, pain in extremity, pain in extremity.  Additional information: Reporter stated that, "I need to know what to do if I should go to the Emergency Room, I already had the (first dose Covid-19 Vaccine) injection for the first time I had it for about a week but I still have lot of pain "needle" (further not clarified) in my body and then I have like whenever I breathing in, it was like I have pain in my chest, my feet and then my sole and then in my fingers everywhere." No Prior vaccine within 4 weeks. When probed for any treatment for the event, consumer stated, "No." Vaccination Anatomical site was right upper arm.   Follow-up attempts completed. No further information expected.
Muscle ache and feeling poorly starting 24 hours after vaccination. Sometimes felt chilled as if she had a fever. But this evening (August 20th, 7:00p), she did feel warm to me (husband).  So took her temperature.... 101.3  If she is feeling bad tomorrow (August 21), we will take her to our primary care physician. We have been reluctant to contact that office because the doctor is against vaccinations, and we got our shots without their knowledge.  My wife had shingles attacks twice in years past.  We had the previous vaccine. She did  not have any reaction to the first dose of Shingrix two months ago.
Painful rash on ''my'' inner right thigh. It is red, itchy and burning to touch; Painful rash on ''my'' inner right thigh. It is red, itchy and burning to touch; Painful rash on ''my'' inner right thigh. It is red, itchy and burning to touch; Painful rash on ''my'' inner right thigh. It is red, itchy and burning to touch; Starts to peel like sunburnt skin and then is fine for a couple weeks before repeating the cycle.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 19May2021 at 14:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 28Apr2021 at 14:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 20May2021 at 18:00, the day after received the second dose, the patient developed a painful rash on her inner right thigh. It was red, itchy and burning to touch. On an unknown date in May2021, after a day or so it started to peel like sunburnt skin and then was fine for a couple weeks before repeating the cycle. On 04Oct2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. On 06Oct2021, the patient underwent SARS-CoV-2 test via spit tub and the result was negative. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19.  The clinical outcome of the events painful rash on inner right thigh, it was red, itchy, burning to touch and started to peel like sunburnt skin were not resolved at the time of this report.
10-15 minutes post vax, the pt passed out and had a seizure. She was cold and clammy, slurred speech, and weak pulse. No shortness of breath.
A consumer reported that she received a dose of Flumist a couple of weeks ago and recently has developed a cold, productive cough, infected sinuses and ears. Relevant medical history was not provided. Indication for Flumist was immunization. Product was administered in 2003. Dose regimen was 1 dose 1 time per day. Concomitant medications were not reported. The patient experienced cold, infected sinuses, ear infection, and productive cough in 2003. No additional information was available at the time of this report.
hard time breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard time breathing) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DYSPNOEA (hard time breathing). On 09-Feb-2021, DYSPNOEA (hard time breathing) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Pt recd 2 vaxs (1cc); 1st dose, "given JUN90 (?)," was uneventful; p/2nd dose, given "JUL90 (?)," Pt felt ill, had grippe/flu-like feeling for a few days; no rx; Pt "got well";  Pt had lack of response to vax; p/2 doses had neg Ab test;
Patient states that she had purple splotches on the right hand, opposite of the arm the dose was administered. We called her in the evening and she reported that they looked better
PATIENT ARRIVED AT 1PM,  SHE WAS APREHENSIVE BECAUSE HER SCHOOL REQUIRED THE VACCINE. PHYSICAL ASSESSMENT WAS COMPLETED, AND THE VACCINATION WAS GIVEN AT 1:03. THERE WAS SOME BLEEDING AT THE VACCINATION SITE, AND THE PATIENT ALMOST IMMEDIATELY SAID SHE COULD NOT HEAR AND HER SIGHT WAS ALTERED. SHE COULD NOT DESCRIBE IN WHAT WAY IT WAS ALTERED, JUST THAT IT " WASN'T RIGHT". PULSE OX AND BLOOD PRESSURE READINGS WERE TAKEN AND ON 1ST ATTEMPT HER O2 WAS 98 AND BP READING LOW AT 77/45. PATIENT WAS A VERY SMALL PERSON, AND A MANUAL BP CUFF WAS USED AND BP WAS 94/62. PATIENT WAS GIVEN WATER, AND WAS TALKING TO HER FRIEND DURING THIS TIME. HER SIGHT, HEARING AND OVERALL ASSESSMENT CAME BACK WITHIN NORMAL RANGE. PATIENT WAS VISIBLY UPSET THAT SHE HAD THIS REACTION AND WAS TOLD IT WAS OK. 911 WAS NOT CALLED, BUT PATIENT WAS ADVISED TO FOLLOW UP WITH STUDENT HEALTH CENTER THERE AT THE COLLEGE.